Real‐World Treatment Patterns and Characteristics of Patients Aged 15 Years and Older Treated With Baricitinib for Alopecia Areata in Japan

    January 2026 in “ Dermatologic Therapy ”
    Kazutoshi Harada, Taisuke Kojima, Yasuhiro Miki … Manabu Ohyama
    Studysummary This study reported that topical corticosteroids are the most common treatment for alopecia areata in Japan, and high treatment persistence was observed with baricitinib, especially when used with other therapies.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 18

    1. Comparison of Current International Guidelines for the Management of Alopecia Areata: Comprehensive Review International Journal of Molecular Sciences · 2025
    2. Psychosocial Impact of Alopecia Areata in Pediatric and Adolescent Populations: A Systematic Review Journal of Paediatrics and Child Health · 2024
    3. Long-Term Efficacy and Safety of Baricitinib in Patients With Severe Alopecia Areata: 104-Week Results From BRAVE-AA1 and BRAVE-AA2 Journal of the European Academy of Dermatology and Venereology · 2024
    4. European Expert Consensus Statement on the Systemic Treatment of Alopecia Areata JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2024
    5. Inhibition of T-Cell Activity in Alopecia Areata: Recent Developments and New Directions Frontiers in immunology · 2023
    6. Economic Burden of Alopecia Areata: A Study of Direct and Indirect Cost in Japan Using Real-World Data Journal of dermatology · 2023
    7. Baricitinib: A Review in Severe Alopecia Areata American Journal of Clinical Dermatology · 2023
    8. Baricitinib for the Treatment of Alopecia Areata Drugs · 2023
    9. Anxiety, Depression, and Quality of Life in Children and Adults With Alopecia Areata: A Systematic Review and Meta-Analysis Frontiers in Medicine · 2022
    10. Prevalence of Alopecia Areata in Japan: Estimates from a Nationally Representative Sample The Journal of Dermatology · 2022
    11. Prevalence, Comorbidities, and Treatment Patterns of Japanese Patients with Alopecia Areata: A Descriptive Study Using Japan Medical Data Center Claims Database The Journal of Dermatology · 2022
    12. Use of H-1 Antihistamine in Dermatology: More Than Itch and Urticaria Control: A Systematic Review Dermatology and Therapy · 2021
    13. The Immunological Association Between Alopecia Areata and Respiratory Diseases: A Systematic Review Skin Appendage Disorders · 2019
    14. Comorbidities in Alopecia Areata: A Systematic Review and Meta-Analysis Journal of The American Academy of Dermatology · 2018
    15. Alopecia Areata: Overview and Insights from January 2018 Journal of The American Academy of Dermatology · 2017
    16. Epidemiology and Burden of Alopecia Areata: A Systematic Review Clinical, Cosmetic and Investigational Dermatology · 2015
    17. Experimental Evaluation of Ebastine, a Second-Generation Antihistamine, as a Supportive Medication for Alopecia Areata Journal of Dermatological Science · 2010
    18. Treatment of Widespread Alopecia Areata in Young Patients with Monthly Oral Corticosteroid Pulse Pediatric Dermatology · 1998